author-photo

Edward Cha

Genentech

31

Papers

615

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or metastatic solid tumors

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b Trial.

2021 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

2021 Gut
Show All
- Source
- Cite
- Save
Citations (1)
Phase Ib/II open-label, randomized evaluation of atezolizumab (atezo) + Imprime PGG (Imprime) + bevacizumab (bev) vs regorafenib (rego) in MORPHEUS: Microsatellite-stable (MSS) metastatic colorectal cancer (mCRC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (37)
Abstract CT201: Phase Ib/II open-label, randomized evaluation of atezolizumab + cobimetinib vs control in MORPHEUS-NSCLC (non-small cell lung cancer), MORPHEUS-PDAC (pancreatic ductal adenocarcinoma) and MORPHEUS-GC (gastric cancer)

2020 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (1)
Phase 1 Study of Epacadostat in Combination With Atezolizumab for Patients With Previously Treated Advanced Non‐Small Cell Lung Cancer

2020 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (12)
MORPHEUS: A phase Ib/II study platform evaluating the safety and clinical efficacy of cancer immunotherapy (CIT)–based combinations in gastrointestinal (GI) cancers.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (52)
1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (6)